EPHA2 and small cell lung carcinoma: Ishigaki et al. presented cell-cycle arrest through the dephosphorylation of retinoblastoma (Rb) as the underlying mechanism of the proliferation inhibition of EPHA2-expressing SCLC cells, after both genetic siRNA EPHA2 inhibition and ALW-II-41-27/dasatinib treatment [63].